KIRKMAN ROBERT L 4/A
4/A · Oncothyreon Inc. · Filed Dec 3, 2010
Insider Transaction Report
Form 4/AAmended
Oncothyreon Inc.ONTY
KIRKMAN ROBERT L
DirectorPresident/CEO
Transactions
- Award
Stock Option (right to buy)
2010-12-01+100,000→ 100,000 totalExercise: $3.32Exp: 2018-12-01→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The option is exercisable at the rate of 25% of the shares on December 1, 2011 and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on December 1, 2014.
- [F2]The Expiration Date was incorrectly stated in the reporting person's original Form 4.